(Press-News.org) The world’s leading stem cell scientists will convene in Hong Kong, SAR, 11-14 June 2025 for the International Society for Stem Cell Research (ISSCR) 2025 Annual Meeting, illuminating the future of stem cell science and highlighting the most compelling research and clinical advances of the year. The meeting is co-sponsored by The University of Hong Kong, The Chinese University of Hong Kong, and Hong Kong University of Science and Technology. The Hong Kong Innovation and Technology Commission and the Hong Kong Convention and Exhibition Centre provided significant support to enable the ISSCR to bring its hallmark event to the city of Hong Kong.
“We are honored to bring the ISSCR Annual Meeting to this region of the world for the first time since 2012 and appreciate the tremendous support of our co-sponsors to bring the meeting to Hong Kong,” Amander Clark, PhD, ISSCR President said. “It has been an incredible few years of basic discoveries and translational advances with stem cells, catapulting our field to the forefront of the most innovative science in the world. We look forward to celebrating the novel achievements of our global community in Hong Kong in 2025.”
For more than 20 years, the ISSCR Annual Meeting has convened bright minds in the stem cell field – to share knowledge, discovery, and diverse perspectives. The meeting represents the latest advances for the full breadth of our field, across multiple axes, including disciplines, geography, and cultures.
“The ISSCR 2025 Annual meeting in Hong Kong presents an unprecedent opportunity for fostering meeting of diverse minds from Asia, Oceania, the Americas and Europe that will inspire and engage stem cell researchers globally and seed international collaborations,” Kathy Cheah, Chair of the Hong Kong Bid Committee, said. “The impact will be huge!”
ISSCR 2025 will take place at the Hong Kong Convention and Exhibition Centre and is also supported by the Hong Kong Tourism Board and the Croucher Foundation Limited.
Be among the first to see the program for ISSCR 2025 by signing up for alerts at ISSCR2025.org. Journalists who are interested in attending the meeting should email kkilbourne@isscr.org.
About the International Society for Stem Cell Research (www.isscr.org)
With nearly 5,000 members from more than 80 countries, the International Society for Stem Cell Research is the preeminent global, cross-disciplinary, science-based organization dedicated to stem cell research and its translation to the clinic. The ISSCR mission is to promote excellence in stem cell science and applications to human health.
About Hong Kong Tourism Board
The Hong Kong Tourism Board (HKTB) is a Government-subvented body. Operating 15 offices around the world and representative offices in seven different markets, its primary mission is to maximize the social and economic contribution that tourism makes to the community of Hong Kong, and consolidate the city’s position as a world-class destination. The HKTB works closely with the Government, travel industry and other partners to promote Hong Kong worldwide, widen the range of tourism products and elevate service standards, as well as enhance the experiences of visitors during their stay.
###
END
A wild male Sumatran orangutan (Pongo abelii) has been observed applying chewed leaves from Akar Kuning (Fibraurea tinctoria) — a climbing plant used in traditional medicine to treat wounds and conditions such as dysentery, diabetes, and malaria — to a wound on his cheek. The findings, which are published in Scientific Reports, represent the first report of suspected wound treatment by a wild animal using a plant with known medicinal properties.
Prior to this study, multiple ...
About The Study: This cohort study found that for the population without a family history of colorectal cancer (CRC), the 10-year interval between colonoscopy screenings for individuals with a first colonoscopy with findings negative for CRC could potentially be extended to 15 years. A longer interval between colonoscopy screenings could be beneficial in avoiding unnecessary invasive examinations.
Authors: Mahdi Fallah, M.D., Ph.D., of the German Cancer Research Center in Heidelberg, is the corresponding ...
About The Study: For individuals who smoked but did not achieve abstinence after treatment with varenicline, increasing the dosage enhanced abstinence versus continuing, whereas for nonabstainers initially treated with combined nicotine replacement therapy, a dosage increase or switch to varenicline enhanced abstinence and may be viable rescue strategies.
Authors: Paul M. Cinciripini, Ph.D., of the University of Texas MD Anderson Cancer Center in Houston, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2024.4183)
Editor’s Note: Please see the article ...
The locus coeruleus (LC) is a small region of the brainstem that produces norepinephrine, a chemical with powerful effects on arousal and wakefulness which plays an important role in the body’s response to stress or panic. Now, research from the University of Chicago shows it plays a specific role in visual sensory processing as well.
In a new study published in Neuron, neuroscientists artificially increased neuronal activity in the LC by briefly shining light on genetically modified neurons. They saw that this manipulation selectively enhanced performance in non-human primates performing a visual attention task, underscoring the crucial role that attention plays in sensory ...
HOUSTON ― For most smokers, quitting on the first attempt is likely to be unsuccessful, but a new study from The University of Texas MD Anderson Cancer Center found patients were more likely to quit if their cessation regimen was altered and doses were increased. Researchers also found that varenicline, a cessation medication, was more effective than combined nicotine replacement therapy (CNRT), such as patches or lozenges.
The study, published today in JAMA, revealed smokers who failed to quit with varenicline in the trial’s first phase were seven times more likely to quit by the end of the second phase if varenicline ...
Long Beach, Calif. – May 2, 2024 – New insights from the AI-ENCODE study showed artificial intelligence (AI) successfully allowed the automated extraction of key functional and physiological data from routine angiograms. The late-breaking results were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2024 Scientific Sessions.
Coronary angiography is a widely used diagnostic procedure for identifying coronary artery disease (CAD), performed in over one million patients annually in the United States. Currently, data extracted from coronary angiograms are confined to detecting blockages in the coronary arteries. However, AI technology ...
Long Beach, Calif. – May 2, 2024 – New data from the CALORI Cardiac Catheterization trial shows significant improvement in patient well-being and satisfaction without compromising safety after implementation of a liberal non-fasting strategy prior to a cardiac catheterization procedures. The late-breaking results were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2024 Scientific Sessions.
More than one million cardiac catheterizations are performed each year in the U.S. to diagnose heart problems. The risk of complications ...
Long Beach, Calif. – May 2, 2024 – Final 12-month data from the EXACT trial demonstrates safety and efficacy results for a vascular endothelial growth factor (VEGF) gene therapy treatment for patients who have advanced coronary artery disease (CAD). The late-breaking results were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2024 Scientific Sessions.
CAD, also known as coronary heart disease or ischemic heart disease, affects about 20.5 million U.S. adults – making it the most common type of heart disease in the ...
Long Beach, Calif. – May 2, 2024 – New data demonstrated that a left main (LM) bifurcation-specific novel scoring system (LM V-RESOLVE), based on three simple baseline angiographic findings, could help to rapidly discriminate lesions at risk of side branch (SB) occlusion during LM bifurcation percutaneous coronary intervention (PCI) – reducing risk during the procedure. The results from the prospective trial were presented today as late-breaking science at the Society for Cardiovascular Angiography & Interventions (SCAI) ...
BALTIMORE, May 2, 2024: Bacterial Vaginosis (BV) affects about one-quarter of reproductive-age women and is linked to adverse health outcomes, such as increased HIV risk. Yet for decades, BV treatment in the United States has largely relied on antibiotics, and BV recurrence is common following antibiotic therapy.
Now, two European clinical trials have shown limited success with a different type of medication used to treat BV called dequalinium chloride (DQC). DQC—an antiseptic—has been in use for several decades in countries throughout Europe as an alternative treatment for BV. It is not currently approved by the U.S. ...
